Lot Release Certificate View

Lot Release Number 2020-10-21-0270
FDA Registered Product/Generic Name Diphtheria, Tetanus, Pertussis (Acellular Component), Hepatitis B, Poliomyelitis (Inactivated) and Haemophilus influenzae Type B Conjugate Vaccine (Adsorbed) [DTap-IPV-HepB-Hib]
Brand Name Hexaxim
Dosage Strength -
Dosage Form Suspension for Injection
Registration Number BR-919
Batch/Lot Number T3B11
Packaging Lot Packaging lot: BOX: T3L774V, PFS: T3L77 Needle 25Gx5/8": 2002001, ED: 2025-01-31; Needle 23Gx1": 1912010, ED: 2024-11-30
Product Expiration Date 31 October 2021
Issuance Date 26 October 2020